Elucidation of the inhibition mechanism of sulfiredoxin using molecular modeling and development of its inhibitors

Minsup Kim, Jinsun Kwon, Ja il Goo, Yongseok Choi, Art E. Cho

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

When intracellular reactive oxygen species (ROS) increase, cancer cells are more vulnerable to oxidative stress compared to normal cells; thus, the collapse of redox homeostasis can lead to selective death of cancer cells. Indeed, recent studies have shown that inhibition of sulfiredoxin (Srx), which participates in antioxidant mechanisms, induces ROS-mediated cancer cell death. In this paper, we describe how an Srx inhibitor, J14 (4-[[[4-[4-(2-chlor-ophenyl)-1-piperazinyl]-6-phenyl-2-pyrimidinyl]thio]methyl]-benzoic acid), interferes with the antioxidant activity of Srx at the molecular level. We searched for possible binding sites of Srx using a binding site prediction method and uncovered two possible inhibition mechanisms of Srx by J14. Using molecular dynamics simulations and binding free energy calculations, we confirmed that J14 binds to the ATP binding site; therefore, J14 acts as a competitive inhibitor of ATP, settling the question of the two mechanisms. Based on the inhibition mechanism revealed at the atomic level, we designed several derivatives of J14, which led to LMT-328 (4-(((4-(4-(2-Chlorophenyl)piperazin-1-yl)-6-(2,4-dihydroxy-5-isopropylphenyl)pyrimidin-2-yl)thio)methyl)benzoic acid), which is possibly an even more potent inhibitor than J14.

Original languageEnglish
Pages (from-to)208-215
Number of pages8
JournalJournal of Molecular Graphics and Modelling
Volume92
DOIs
Publication statusPublished - 2019 Nov 1

Fingerprint

Molecular modeling
Binding sites
inhibitors
Benzoic Acid
Benzoic acid
Adenosinetriphosphate
Binding Sites
Antioxidants
adenosine triphosphate
cancer
Reactive Oxygen Species
benzoic acid
antioxidants
Adenosine Triphosphate
Cells
death
Oxygen
Oxidative stress
Cell death
homeostasis

Keywords

  • Chemical study
  • Molecular dynamics simulation
  • Molecular modeling
  • Peroxiredoxin
  • Sulfiredoxin

ASJC Scopus subject areas

  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Computer Graphics and Computer-Aided Design
  • Materials Chemistry

Cite this

Elucidation of the inhibition mechanism of sulfiredoxin using molecular modeling and development of its inhibitors. / Kim, Minsup; Kwon, Jinsun; Goo, Ja il; Choi, Yongseok; Cho, Art E.

In: Journal of Molecular Graphics and Modelling, Vol. 92, 01.11.2019, p. 208-215.

Research output: Contribution to journalArticle

@article{7c3468221f384c12be2ffd3150521996,
title = "Elucidation of the inhibition mechanism of sulfiredoxin using molecular modeling and development of its inhibitors",
abstract = "When intracellular reactive oxygen species (ROS) increase, cancer cells are more vulnerable to oxidative stress compared to normal cells; thus, the collapse of redox homeostasis can lead to selective death of cancer cells. Indeed, recent studies have shown that inhibition of sulfiredoxin (Srx), which participates in antioxidant mechanisms, induces ROS-mediated cancer cell death. In this paper, we describe how an Srx inhibitor, J14 (4-[[[4-[4-(2-chlor-ophenyl)-1-piperazinyl]-6-phenyl-2-pyrimidinyl]thio]methyl]-benzoic acid), interferes with the antioxidant activity of Srx at the molecular level. We searched for possible binding sites of Srx using a binding site prediction method and uncovered two possible inhibition mechanisms of Srx by J14. Using molecular dynamics simulations and binding free energy calculations, we confirmed that J14 binds to the ATP binding site; therefore, J14 acts as a competitive inhibitor of ATP, settling the question of the two mechanisms. Based on the inhibition mechanism revealed at the atomic level, we designed several derivatives of J14, which led to LMT-328 (4-(((4-(4-(2-Chlorophenyl)piperazin-1-yl)-6-(2,4-dihydroxy-5-isopropylphenyl)pyrimidin-2-yl)thio)methyl)benzoic acid), which is possibly an even more potent inhibitor than J14.",
keywords = "Chemical study, Molecular dynamics simulation, Molecular modeling, Peroxiredoxin, Sulfiredoxin",
author = "Minsup Kim and Jinsun Kwon and Goo, {Ja il} and Yongseok Choi and Cho, {Art E.}",
year = "2019",
month = "11",
day = "1",
doi = "10.1016/j.jmgm.2019.07.018",
language = "English",
volume = "92",
pages = "208--215",
journal = "Journal of Molecular Graphics and Modelling",
issn = "1093-3263",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Elucidation of the inhibition mechanism of sulfiredoxin using molecular modeling and development of its inhibitors

AU - Kim, Minsup

AU - Kwon, Jinsun

AU - Goo, Ja il

AU - Choi, Yongseok

AU - Cho, Art E.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - When intracellular reactive oxygen species (ROS) increase, cancer cells are more vulnerable to oxidative stress compared to normal cells; thus, the collapse of redox homeostasis can lead to selective death of cancer cells. Indeed, recent studies have shown that inhibition of sulfiredoxin (Srx), which participates in antioxidant mechanisms, induces ROS-mediated cancer cell death. In this paper, we describe how an Srx inhibitor, J14 (4-[[[4-[4-(2-chlor-ophenyl)-1-piperazinyl]-6-phenyl-2-pyrimidinyl]thio]methyl]-benzoic acid), interferes with the antioxidant activity of Srx at the molecular level. We searched for possible binding sites of Srx using a binding site prediction method and uncovered two possible inhibition mechanisms of Srx by J14. Using molecular dynamics simulations and binding free energy calculations, we confirmed that J14 binds to the ATP binding site; therefore, J14 acts as a competitive inhibitor of ATP, settling the question of the two mechanisms. Based on the inhibition mechanism revealed at the atomic level, we designed several derivatives of J14, which led to LMT-328 (4-(((4-(4-(2-Chlorophenyl)piperazin-1-yl)-6-(2,4-dihydroxy-5-isopropylphenyl)pyrimidin-2-yl)thio)methyl)benzoic acid), which is possibly an even more potent inhibitor than J14.

AB - When intracellular reactive oxygen species (ROS) increase, cancer cells are more vulnerable to oxidative stress compared to normal cells; thus, the collapse of redox homeostasis can lead to selective death of cancer cells. Indeed, recent studies have shown that inhibition of sulfiredoxin (Srx), which participates in antioxidant mechanisms, induces ROS-mediated cancer cell death. In this paper, we describe how an Srx inhibitor, J14 (4-[[[4-[4-(2-chlor-ophenyl)-1-piperazinyl]-6-phenyl-2-pyrimidinyl]thio]methyl]-benzoic acid), interferes with the antioxidant activity of Srx at the molecular level. We searched for possible binding sites of Srx using a binding site prediction method and uncovered two possible inhibition mechanisms of Srx by J14. Using molecular dynamics simulations and binding free energy calculations, we confirmed that J14 binds to the ATP binding site; therefore, J14 acts as a competitive inhibitor of ATP, settling the question of the two mechanisms. Based on the inhibition mechanism revealed at the atomic level, we designed several derivatives of J14, which led to LMT-328 (4-(((4-(4-(2-Chlorophenyl)piperazin-1-yl)-6-(2,4-dihydroxy-5-isopropylphenyl)pyrimidin-2-yl)thio)methyl)benzoic acid), which is possibly an even more potent inhibitor than J14.

KW - Chemical study

KW - Molecular dynamics simulation

KW - Molecular modeling

KW - Peroxiredoxin

KW - Sulfiredoxin

UR - http://www.scopus.com/inward/record.url?scp=85070113721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070113721&partnerID=8YFLogxK

U2 - 10.1016/j.jmgm.2019.07.018

DO - 10.1016/j.jmgm.2019.07.018

M3 - Article

AN - SCOPUS:85070113721

VL - 92

SP - 208

EP - 215

JO - Journal of Molecular Graphics and Modelling

JF - Journal of Molecular Graphics and Modelling

SN - 1093-3263

ER -